Estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] — RxCUI 150840
RxNorm drug concept · Semantic branded drug
RxCUI 150840
Semantic branded drug · SBD
● Current RxNorm concept 11 FDA products
17 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI150840
Official nameEstrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPremarin 0.625 MG Oral Tablet
FDA products mapped11
Package NDCs mapped17
Reported Medicaid activity (SDUD)108,937 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Estrogens, conjugated (USP) 0.625 MG Oral Tablet... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin]
RxCUI 150840 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Estrogens, conjugated (USP)
4099IN
-
Estrogens, conjugated (USP)
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Premarin
202896BN
-
Premarin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Estrogens, conjugated (USP) Oral Tablet
378834SCDF -
Estrogens, conjugated (USP) Oral Product
1165792SCDG -
Estrogens, conjugated (USP) Pill
1165793SCDG -
Estrogens, conjugated (USP) Oral Tablet [Premarin]
369405SBDF -
Premarin Oral Product
1185837SBDG -
Premarin Pill
1185838SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Estrogens, conjugated (USP) Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Estrogens, conjugated (USP) 0.625 MG Oral Tablet
310197SCD -
Estrogens, conjugated (USP) 0.625 MG
343477SCDC -
Estrogens, conjugated (USP) 0.625 MG [Premarin]
564825SBDC
-
Estrogens, conjugated (USP) 0.625 MG Oral Tablet
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Estrogens, conjugated (USP) 0.625 MG Oral Tablet
SCD · 310197 -
{14 (estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 5 MG Oral Tablet) / 14 (estrogens, conjugated (USP) 0.625 MG Oral Tablet) } Pack
GPCK · 1000486 -
Estrogens, conjugated (USP) 0.625 MG
SCDC · 343477 -
Estrogens, conjugated (USP) Oral Tablet
SCDF · 378834 -
Estrogens, conjugated (USP) Oral Product
SCDG · 1165792 -
Estrogens, conjugated (USP) Pill
SCDG · 1165793
Brand-Name Concepts
-
Estrogens, conjugated (USP) 0.625 MG [Premarin]
SBDC · 564825 -
Estrogens, conjugated (USP) Oral Tablet [Premarin]
SBDF · 369405 -
Premarin Oral Product
SBDG · 1185837 -
Premarin Pill
SBDG · 1185838 -
Premarin
BN · 202896
📦 FDA Products & Package NDCs
11 products · 17 package NDCs
17 package NDCs map to RxCUI 150840 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00046-1100-52 | 1 BLISTER PACK in 1 CARTON (0046-1100-52) / 5 TABLET, FILM... | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2019-11-11 |
| 00046-1100-81 | 100 TABLET, FILM COATED in 1 BOTTLE (0046-1100-81) | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2006-01-01 |
| 00046-1100-91 | 1 BOTTLE in 1 CARTON (0046-1100-91) / 1000 TABLET, FILM COA... | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2006-01-01 |
| 00046-1101-81 | 100 TABLET, FILM COATED in 1 BOTTLE (0046-1101-81) | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2006-01-01 |
| 00046-1102-52 | 1 BLISTER PACK in 1 CARTON (0046-1102-52) / 5 TABLET, FILM... | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2020-02-10 |
| 00046-1102-81 | 100 TABLET, FILM COATED in 1 BOTTLE (0046-1102-81) | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2006-01-01 |
| 00046-1102-91 | 1 BOTTLE in 1 CARTON (0046-1102-91) / 1000 TABLET, FILM COA... | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2006-01-01 |
| 00046-1103-81 | 100 TABLET, FILM COATED in 1 BOTTLE (0046-1103-81) | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2006-01-01 |
| 00046-1104-81 | 100 TABLET, FILM COATED in 1 BOTTLE (0046-1104-81) | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2004-09-01 |
| 00046-1104-91 | 1 BOTTLE in 1 CARTON (0046-1104-91) / 1000 TABLET, FILM COA... | Premarin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2004-09-01 |
| 00046-1105-11 | 1 BLISTER PACK in 1 CARTON (0046-1105-11) / 28 TABLET, SUGA... | Prempro | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2009-09-21 |
| 00046-1106-11 | 1 BLISTER PACK in 1 CARTON (0046-1106-11) / 28 TABLET, SUGA... | Prempro | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2009-09-21 |
| 00046-1107-11 | 1 BLISTER PACK in 1 CARTON (0046-1107-11) / 28 TABLET, SUGA... | Prempro | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2009-09-21 |
| 00046-1108-11 | 1 BLISTER PACK in 1 CARTON (0046-1108-11) / 28 TABLET, SUGA... | Prempro | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2012-12-03 |
| 00046-2575-12 | 1 BLISTER PACK in 1 CARTON (0046-2575-12) / 1 KIT in 1 BLIS... | Premphase | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 2012-03-01 |
| 50090-0167-00 | 100 TABLET, FILM COATED in 1 BOTTLE (50090-0167-0) | Premarin | A-S Medication Solutions | 2018-10-29 |
| 50090-0167-05 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-0167-5) | Premarin | A-S Medication Solutions | 2016-06-21 |
Observed labelers:
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. (15) ·
A-S Medication Solutions (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.